The high expression of Cyr-61 or COX-2 was associated with invasion, lymph node metastasis, distant metastases, poor histological differentiation, advanced TNM stage and lower 5-year survival rate (all p < 0.05). Here, PTGS2 is linked to metastatic malignant neoplasm in the lymph nodes.